"Caffeine for treatment of Parkinson disease" Ronald B. Postuma, MD, MSc, Anthony E. Lang, MD, Renato P. Munhoz, MD, Katia Charland, PhD, Amelie Pelletier, PhD, Mariana Moscovich, MD, Luciane Filla, MD, Debora Zanatta, RPh, Silvia Rios Romenets, MD, Robert Altman, MD, Rosa Chuang, MD and Binit Shah, MD. doi:10.1212/WNL.0b013e318263570d August 1, 2012. Abstract. Accessed 15 December 2013.
Other studies have tried to pinpoint exactly what in caffeine is helping to halt the onset of these diseases. A 2014 study (14) found that caffeine blocks various tau receptors (a protein that contributes to brain cell degeneration). Another study found that caffeinated coffee increased GCSF (15) - a substance greatly decreased in Alzheimer’s patients - levels in the bloodstream.
×